NCT04927377Completed
Accessible and Inclusive Diabetes Telecoaching Self-Management Program
Accessible and Inclusive Diabetes Telecoaching Self-Management Program: Protocol for a Feasibility Study
Source: ClinicalTrials.gov · Last updated 18 Dec 2025
Brief summary (registry, in English)
The purpose of this study is to develop and pilot test an accessible and inclusive Artificial Intelligence (AI)-assisted, individualized, family-focused lifestyle modification intervention (AI4DM) for glycemic control in people with disabilities.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 90 (actual)
- First submitted
- 4 Jun 2021
- Start date
- 31 Oct 2022
- Primary completion date
- 30 Sept 2025
- Lead sponsor
- University of Alabama at Birmingham
- Diseases
- Type 2 diabetes
- NCT number
- NCT04927377
What you commit to
- Study type: Interventional
- Participants enrolled: 90
- From 31 Oct 2022 to the primary completion date, 30 Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Current enrollment in any diabetes-related intervention
- Major cardiac event in the past twelve months
- Renal failure
Other
- Severe untreated depression in the past six months
- Uncontrolled blood pressure
- Resting tachycardia
- Severe peripheral neuropathy
- Unavailability of a smartphone
Who the study is looking for
- Diagnosis of Type 2 Diabetes Mellitus,
- Living with a permanent physical disability such as spinal cord injury (SCI), spina bifida, multiple sclerosis, stroke, etc.
- Ability to converse and read in English
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Alabama at Birmingham Coordinator of this site? Confirm its status | Birmingham | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.